GGPS1 Gene - Geranylgeranyl Diphosphate Synthase 1

Key enzyme in the mevalonate pathway for protein prenylation and cellular signaling

Gene Information Card

Symbol GGPS1
Full Name Geranylgeranyl Diphosphate Synthase 1
Gene Type Protein coding
Chromosomal Location 1q42.3
NCBI Gene ID 9453 ncbi.nlm.nih.gov/gene/9453
Ensembl ID ENSG00000143178
UniProt ID O95749
OMIM ID 606982
HGNC ID 4249
Aliases GGPPS, GGPP synthase, geranylgeranyl pyrophosphate synthase

Description

GGPS1 encodes geranylgeranyl diphosphate synthase 1, a key enzyme in the mevalonate pathway that catalyzes the synthesis of geranylgeranyl diphosphate (GGPP) from farnesyl diphosphate (FPP) and isopentenyl diphosphate (IPP). GGPP is essential for protein prenylation, a post-translational modification critical for membrane localization and function of small GTPases such as Rho, Rac, and Cdc42. The enzyme functions as a homodimer and is involved in cellular signaling, proliferation, and differentiation.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hereditary Spastic Paraplegia (HSP) Loss-of-function mutations in GGPS1 impair GGPP synthesis, disrupting protein prenylation and axonal transport in motor neurons. ClinVar; PMID: 32707084
Charcot-Marie-Tooth Disease Type 2 Missense variants in GGPS1 cause peripheral neuropathy via defective prenylation of small GTPases. OMIM #606982; PMID: 32707084
Cancer (multiple types) Overexpression of GGPS1 in tumors promotes geranylgeranylation of oncogenic GTPases, enhancing cell proliferation and metastasis. COSMIC; PMID: 25691885

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 38.2 High
Adrenal gland 22.5 Medium
Liver 18.7 Medium
Brain (cerebellum) 15.3 Medium
Heart 12.1 Medium
Lung 9.8 Low
Kidney 8.5 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 25.4 Embryonic kidney cells; high expression
HeLa 20.1 Cervical carcinoma; moderate expression
HepG2 18.9 Hepatocellular carcinoma; moderate expression
A549 15.2 Lung carcinoma; moderate expression
K562 12.3 Leukemia; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.100G>A (p.Gly34Arg) Missense Rare Loss of enzymatic activity; associated with HSP
c.769C>T (p.Arg257Trp) Missense Rare Reduced GGPP production; linked to CMT2
c.1120_1121insA (p.Thr374Asnfs*12) Frameshift Very rare Premature truncation; loss of function
c.854A>G (p.Asn285Ser) Missense Rare Decreased dimer stability; pathogenic
Mutation functional classification

Loss of Function (LOF)

Missense and frameshift mutations that reduce or abolish GGPS1 enzymatic activity, leading to decreased GGPP levels and impaired prenylation of small GTPases.

Gain of Function (GOF)

Not reported; no activating mutations have been described in GGPS1.

Dominant Negative (DN)

Some missense variants (e.g., p.Gly34Arg) may exert dominant-negative effects by forming inactive heterodimers with wild-type enzyme.

Pathways

Mevalonate pathway (KEGG: hsa00900)
Terpenoid backbone biosynthesis (KEGG: hsa00900)
Protein prenylation (Reactome: R-HSA-597592)

Protein Summary

The GGPS1 protein (UniProt O95749) is a 374-amino acid homodimeric enzyme localized primarily in the cytosol and mitochondria. It catalyzes the condensation of farnesyl diphosphate (FPP) with isopentenyl diphosphate (IPP) to form geranylgeranyl diphosphate (GGPP), a 20-carbon isoprenoid lipid. GGPP is a substrate for geranylgeranyltransferase I and II, which modify C-terminal cysteine residues of small GTPases (e.g., Rho, Rac, Rab) for membrane anchoring. The enzyme contains two conserved aspartate-rich motifs (DDXXD) essential for substrate binding and catalysis. Structural studies reveal a dimeric alpha-helical fold with a central active site cavity.

Related Products

Product name Cat.No. Species Gene ID
Contact Us
*
*
*
*
How did you hear about us: